" /> PCWG Bubley Prostate Cancer 1999 Oncology Response Criteria - CISMeF





Preferred Label : PCWG Bubley Prostate Cancer 1999 Oncology Response Criteria;

NCIt related terms : PCWG BUBLEY PROSTATE CANCER 1999; PCWG1;

Alternative definition : CDISC: Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. (Bubley GJ, Carducci M, Dahut W, Dawson N, Daliani D, Eisenberger M, Figg WD, Freidlin B, Halabi S, Hudes G, Hussain M, Kaplan R, Myers C, Oh W, Petrylak DP, Reed E, Roth B, Sartor O, Scher H, Simons J, Sinibaldi V, Small EJ, Smith MR, Trump DL, Wilding G, et al. Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol. 1999 Nov;17(11):3461-7.);

NCI Metathesaurus CUI : CL504636;

Details


You can consult :


Nous contacter.
01/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.